Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4NZ
|
||||
Former ID |
DCL001251
|
||||
Drug Name |
Velneperit
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Obesity [ICD9: 278; ICD10:E66] | Discontinued in Phase 2 | [532488] | ||
Company |
Shionogi & Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H24F3N3O3S
|
||||
Canonical SMILES |
CC(C)(C)S(=O)(=O)NC1CCC(CC1)C(=O)NC2=NC=C(C=C2)C(F)(F)F
|
||||
InChI |
1S/C17H24F3N3O3S/c1-16(2,3)27(25,26)23-13-7-4-11(5-8-13)15(24)22-14-9-6-12(10-21-14)17(18,19)20/h6,9-11,13,23H,4-5,7-8H2,1-3H3,(H,21,22,24)
|
||||
InChIKey |
WGEWUYACXPEFPO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor 5 | Target Info | Antagonist | [551685] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.